The PE Ratio as of November 2024 (TTM) for Omega Therapeutics, Inc. (OMGA) is -0.60

According to Omega Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.60. This represents a change of -66.53% compared to the average of -1.79 of the last 4 quarters.

Omega Therapeutics, Inc. (OMGA) Historical PE Ratio (quarterly & annually)

How has OMGA PE Ratio performed in the past?

The mean historical PE Ratio of Omega Therapeutics, Inc. over the last ten years is -15.76. The current -0.60 PE Ratio has changed 280.65% with respect to the historical average. Over the past ten years (40 quarters), OMGA's PE Ratio was at its highest in in the September 2024 quarter at -1.02. The PE Ratio was at its lowest in in the March 2020 quarter at -22.98.

Omega Therapeutics, Inc. (OMGA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Omega Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Omega Therapeutics, Inc. (OMGA) Average PE Ratio

How has OMGA PE Ratio performed in the past?

The current PE Ratio of Omega Therapeutics, Inc. (OMGA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Omega Therapeutics, Inc. (OMGA) PE Ratio vs. Peers

How is OMGA’s PE Ratio compared to its peers?

Omega Therapeutics, Inc.’s PE Ratio is greater than PMV Pharmaceuticals, Inc. (-1.61), greater than Eliem Therapeutics, Inc. (-2.42), less than MediciNova, Inc. (-0.04), greater than Pharvaris N.V. (-8.69), greater than PepGen Inc. (-1.65), greater than Olema Pharmaceuticals, Inc. (-4.10), greater than Nuvectis Pharma, Inc. (-4.54), greater than Larimar Therapeutics, Inc. (-6.07), greater than Centessa Pharmaceuticals plc (-12.26), greater than Orchestra BioMed Holdings, Inc. (-3.76), greater than Aerovate Therapeutics, Inc. (-0.91), greater than Enliven Therapeutics, Inc. (-13.90), greater than MoonLake Immunotherapeutics (-42.02), greater than Structure Therapeutics Inc. (-14.91), greater than Compass Therapeutics, Inc. (-4.48), greater than Mineralys Therapeutics, Inc. (-4.06), greater than Cadrenal Therapeutics, Inc. Common Stock (-2.18),

Build a custom stock screener for Omega Therapeutics, Inc. (OMGA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omega Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Omega Therapeutics, Inc. (OMGA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Omega Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.